All news

Assenagon cuts Labcorp stake 57.6% in third quarter

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Assenagon Asset Management cut its Labcorp Holdings stake by 57.6% in the third quarter, selling 39,926 shares. Institutions still own 95.94% of the company. Analysts rate Labcorp a "Moderate Buy" with a consensus price target of $337.73, and the company recently beat earnings expectations on a 5.8% year-over-year revenue increase.

Read original source

LH company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.